Related Experiment Video
Updated: Apr 7, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.8K
Correlation analysis of gene polymorphisms and β-lactam allergy
Jing Li1, Xin-yue Liu, Lin-jing Li
1Centre of Laboratory Medicine, Lanzhou University Second Hospital, Lanzhou 730030, China; School of Basic Medical Science, Lanzhou University, Lanzhou 730030, China.
Journal of Zhejiang University. Science. B
|July 11, 2015
Summary
This study investigated genetic variations in Han Chinese individuals and found a significant association between a specific CYP3A4 gene variant and beta-lactam allergy in males. Other gene polymorphisms showed no significant correlation.
Area of Science:
- Immunogenetics
- Pharmacogenomics
Background:
- Beta-lactam antibiotics are widely used, but allergies can cause severe reactions.
- Genetic factors may influence susceptibility to beta-lactam allergy.
- Previous research has not fully elucidated the genetic underpinnings of beta-lactam allergy.
Purpose of the Study:
- To analyze the relationship between beta-lactam allergy and specific single nucleotide polymorphisms (SNPs) in immune-related genes and CYP3A4.
- To investigate genetic associations within the Han Chinese population in Northwest China.
Main Methods:
- Case-control study involving 64 patients with beta-lactam allergy and 30 controls.
- Genotyping of 10 SNPs in IL-10, IL-13, IL-4Rα, FcεRIβ, IFNGR2, and CYP3A4 using Sequenom MassARRAY.
- Statistical analysis with SPSS 17.0 and haplotype analysis using SHEsis.
Main Results:
- A significant difference in the genotype distribution of CYP3A4 rs2242480/CT was observed between male cases and controls (P=0.022, OR=0.167).
- No significant correlation was found for IL-10 haplotypes (CCA, CCG, TAA) with beta-lactam allergy.
- Further investigation is needed for IL-13 haplotypes (CCT, CAC) and their association with beta-lactam allergy.
Conclusions:
- The CYP3A4 rs2242480/CT genotype may be a protective factor against beta-lactam allergy in Han Chinese males.
- Genetic variations in IL-10 and other studied genes do not appear to be significantly associated with beta-lactam allergy in this population.
- Further research is warranted to explore the role of IL-13 gene variants in beta-lactam allergy.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
69
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
119
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
119
01:11Genome-wide Association Studies-GWAS
16.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.7K
01:27Pharmacogenetics of Drug Metabolism: Overview
137
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
137
01:25Clinical Significance of Antibiotic Resistance
43
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
43
01:27Principles of Pharmacogenetics: Types of Genetic Variants
102
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
102